The share structure for ONCX is substantially more messy than when Oncolix emerged from AEPP. The last thing Redman did was to increase authorized shares to 250 billion. ONCX has been rode hard and put away wet. It doesn't seem like an especially attractive vehicle for any hopeful young development stage companies, but I'd be happy to go along for the ride.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.